Bishkek, Nov. 12, 2026 /Kabar/. Kara-Balta of Chui region to have investment project on construction of pharmaceutical manufacturing complex with a total investment of $41.2 million, the National Investment Agency reports.
The facility plans to produce medicinal drugs, gelatin capsules, and physiological solutions, while creating approximately 300 new jobs.
On November 11, Ravshanbek Sabirov, Head of the National Investment Agency under the President of Kyrgyzstan inspected the progress of the project, which is being developed by the company "Standard Pharm Group."
According to the agency, the project aims to foster the growth of domestic pharmaceutical manufacturing, increase the output of medical products, and reduce reliance on imports.
During the site visit, the parties discussed the current status of construction and the prospects for the enterprise's future development.
Ravshanbek Sabirov also highlighted the company’s positive initiative of training local students and subsequently hiring them for positions at the facility. He underscored the importance of cultivating a skilled domestic workforce and creating further opportunities for the professional development of young people.
